PGY-2 Pain and Palliative Care Residency Director
Mark Holtsman, Pharm.D.
At UCDMC since: 1988
Program Director since: 2009
As Co-Director of the Inpatient Pain Service at UC Davis Medical Center and as the Clinical Professor of Anesthesiology and Pain Medicine at the University ofCalifornia Davis School of Medicine, Dr. Holtsman constantly works to provide education in Pain Management to pharmacists, physicians, and nurses. He hasworked with the Pain Management Service at UC Davis Medical Center since 1991 and has been the Pain Management Service Pharmacist since 1996, where he developed a Pain Management Rotation for pharmacy students and residents. In 2004, he became Co-Director of the Inpatient Pain Service with responsibility for education of Anesthesia Pain Fellows, Residents, and Medical Students in Anesthesiology and Pain Medicine at UC Davis Medical Center. He lectures all over the Northwest on Pain Management and currently works as a faculty member in Anesthesiology and Pain Medicine at UC Davis Medical Center. He recentlyspent one month as a Visiting Professor in Japan at Kobe Gakuin University and taught Pain and Palliative Care to pharmacy students. His major research interests include investigating barriers to opioid prescribing, pharmacist knowledge and attitudes about controlled substance prescribing laws, and breakthrough pain treatment in cancer patients. He has worked on projects to improve PCA safety, PCA documentation, fentanyl transdermal system use, and methadone use by helping to develop tools within the health system’s electronic medical record, working to educate staff on importance of documentation, and auditing changes before and after implementation to assess effectiveness of interventions.
Holtsman M, Wilsey BL, Opioids Used for Mild to Moderate Pain. In: Benzon HT, Raja SN, Liu SS, Fishman SM, Cohen SP eds.Essentials of Pain Medicine and Regional Anesthesia. Philadelphia: Elsevier Churchill Livingstone; 2011: 97-100.
Mahajan G, Sheth S,Holtsman M, Major Opioids in Pain Management. In: Benzon HT, Raja SN, Liu SS, Fishman SM, Cohen SP eds.Essentials of Pain Medicine and Regional Anesthesia. Philadelphia: Elsevier Churchill Livingstone; 2011: 85-96.
Improving Adherence to Fentanyl Transdermal System Black Box Warnings by Adding Questions to Physician Order Entry. Aaron J. Prince, PharmD, Ashley Trask, PharmD, Patricia Parker, Mark L. Holtsman, PharmD Abstract 149 Pain Med. 2011 Mar;12(3):486.
Opioid Dose Evaluation for Breakthrough Pain and Its Proportionality to the Total Opioid Dose in Cancer Patients with Chronic Opioid Use. Nguyen M, and Holtsman M. Abstract 196 Pain Med. 2009 Jan;10(1):247.
Commentary on Dr. Heit and Dr. Gilson’s letter to the Drug Enforcement Administration. Does your Pharmacist Interpret a New Federal Standard in a Manner that Can Make your Patient Suffer in Pain? Holtsman M. Pain Med. 2008 Oct;9(7):927.
Fentanyl buccal tablets effective for pediatric patient with episodic pain secondary to ulcerative coloitis. Holtsman ML, Wania-Galicia L, and Williamson D. J Pain 9(4) Supp 1 April 2008 Page 39 Abstract 253 Presented at American Pain Society Annual Meeting May 2008.
Ending triplicate prescription use in California: The effect on prescribing patterns of controlled substances, Cello R, Holtsman M, and Mowers R. J Pain, April 2007: 8:4:S86 Abstract.
Evaluating the effectiveness of a pharmacist-managed pain consult service in postoperativeknee replacement patients. Yacoub, C, Liang L, Ryu J, Thongsinthusak T, andHoltsman M. Abstract 290, ACCP Annual Meeting, St. Louis, Missouri October 2006.
Holtsman M, Fishman SM. Opioid Receptors. In: Benzon HT, Raja SN, Molloy RE, Liu SS, Fishman SM eds.
Essentials of Pain Medicine and Regional Anesthesia. Philadelphia: Elsevier Churchill Livingstone; 2005: 87-93.
Fishman SM, Condon J, Holtsman ML. Common Opioid-Related Side Effects. In: Warfield CA, Bajwa ZH eds. PRINCIPLES AND PRACTICE OF PAIN MEDICINE. New York: McGraw-Hill; 2004: 612-615.